Caregen Co., Ltd. (KOSDAQ:214370)

South Korea flag South Korea · Delayed Price · Currency is KRW
33,500
-1,200 (-3.46%)
Jun 5, 2025, 3:30 PM KST
40.17%
Market Cap 1.64T
Revenue (ttm) 83.43B
Net Income (ttm) 31.22B
Shares Out 48.87M
EPS (ttm) 635.97
PE Ratio 52.68
Forward PE 32.37
Dividend 640.00 (1.84%)
Ex-Dividend Date Jun 27, 2025
Volume 79,978
Average Volume 163,399
Open 34,400
Previous Close 34,700
Day's Range 33,350 - 34,950
52-Week Range 14,850 - 36,500
Beta 0.35
RSI 58.21
Earnings Date May 9, 2025

About Caregen

Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name. It is also developing medicines for COVID-19 treatment, wet macular degeneration, dry macular degeneration, antivira... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 192
Stock Exchange KOSDAQ
Ticker Symbol 214370
Full Company Profile

Financial Performance

In 2024, Caregen's revenue was 82.59 billion, an increase of 4.26% compared to the previous year's 79.21 billion. Earnings were 32.31 billion, a decrease of -19.07%.

Financial Statements

News

Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen

Akums Drugs and Pharmaceuticals saw a 5% jump in its stock price after signing an exclusive Master Sales Agreement with South Korea-based Caregen Co., Ltd. The deal gives Akums exclusive rights to pac...

7 months ago - Business Upturn

Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion

Akums Drugs and Pharmaceuticals Ltd., a leading name in the pharmaceutical industry, has signed an exclusive Master Sales Agreement with South Korea’s Caregen Co., Ltd. This partnership grants Akums e...

7 months ago - Business Upturn